Literature DB >> 16625109

Contrast bolus optimization for cardiac 16-slice computed tomography: comparison of contrast medium formulations containing 300 and 400 milligrams of iodine per milliliter.

Carsten Rist1, Konstantin Nikolaou, Miles A Kirchin, Roland van Gessel, Kyongtae Ty Bae, Franz von Ziegler, Andreas Knez, Bernd J Wintersperger, Maximilian F Reiser, Christoph R Becker.   

Abstract

OBJECTIVES: The aims of our study were to compare contrast injection protocols with contrast media containing 300 and 400 mg iodine per milliliter for optimal contrast enhancement in cardiac multidector row computed tomography (CT) and to evaluate the correlation of test bolus curve parameters with the final contrast density of the main bolus.
MATERIALS AND METHODS: Sixty patients with known or suspected coronary artery disease were included in a prospective double-blind study. Patients were randomized to 2 groups. Group 1 received 83 mL of a contrast medium (CM) containing 300 mg of iodine (Iomeron 300, Bracco Imaging SpA, Milan, Italy) at a flow rate of 3.3 mL/s, whereas group 2 received 63 mL of the same agent containing 400 mg of iodine (Iomeron 400) at a flow rate of 2.5 mL/s. The test bolus volumes were 20 mL and 15 mL, respectively. Imaging was performed using a 16-slice CT system (16DCT; Somatom Sensation 16, Siemens Medical Solutions, Forchheim, Germany). Contrast densities (Hounsfield Units [HU]) were determined in the cardiac chambers and in the main coronary arteries. The peak density and area under the curve of the test bolus were calculated for each patient.
RESULTS: The mean contrast densities of the coronary arteries were 259.1 +/- 46.7 HU for group 1 and 251.6 +/- 51.0 HU, for group 2. No noteworthy differences between groups were noted for density measurements in the cardiac chambers or for the ratio of right-to-left ventricle density. Whereas a positive correlation was noted for both groups between the area under the curve of the test bolus and the mean density of the main bolus, a positive correlation between peak density of the test bolus and mean density of the main bolus was noted only for group 1.
CONCLUSION: Equivalent homogenous enhancement of the ventricular cavities and coronary arteries to that obtained using a CM with standard iodine concentration (Iomeron 300) can be achieved with lower overall volumes of administered CM and reduced injection flow rates when a CM with high iodine concentration (Iomeron 400) is used.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16625109     DOI: 10.1097/01.rli.0000208239.34723.5d

Source DB:  PubMed          Journal:  Invest Radiol        ISSN: 0020-9996            Impact factor:   6.016


  21 in total

1.  Dose levels at coronary CT angiography--a comparison of Dual Energy-, Dual Source- and 16-slice CT.

Authors:  J Matthias Kerl; Ralf W Bauer; Tobias B Maurer; Rene Aschenbach; Huedayi Korkusuz; Thomas Lehnert; Simon Deseive; Hanns Ackermann; Thomas J Vogl
Journal:  Eur Radiol       Date:  2010-09-23       Impact factor: 5.315

2.  Influence of intra-coronary enhancement on diagnostic accuracy with 64-slice CT coronary angiography.

Authors:  Filippo Cademartiri; Erica Maffei; Anselmo Alessandro Palumbo; Roberto Malagò; Ludovico La Grutta; W Bob Meiijboom; Annachiara Aldrovandi; Michele Fusaro; Luigi Vignali; Alberto Menozzi; Valerio Brambilla; Paolo Coruzzi; Massimo Midiri; Miles A Kirchin; Nico R A Mollet; Gabriel P Krestin
Journal:  Eur Radiol       Date:  2007-10-13       Impact factor: 5.315

3.  MDCT angiography of the pulmonary arteries: intravascular contrast enhancement does not depend on iodine concentration when injecting equal amounts of iodine at standardized iodine delivery rates.

Authors:  S Keil; C Plumhans; F F Behrendt; M Das; S Stanzel; G Mühlenbruch; P Seidensticker; C Knackstedt; A H Mahnken; R W Günther; J E Wildberger
Journal:  Eur Radiol       Date:  2008-04-08       Impact factor: 5.315

4.  Intra-individual comparison of different contrast media concentrations (300 mg, 370 mg and 400 mg iodine) in MDCT.

Authors:  Florian F Behrendt; Hubertus Pietsch; Gregor Jost; Martin A Sieber; Sebastian Keil; Cedric Plumhans; Peter Seidensticker; Rolf W Günther; Andreas H Mahnken
Journal:  Eur Radiol       Date:  2010-02-24       Impact factor: 5.315

5.  Challenges to protocol optimization due to unexpected variation of CT contrast dose amount and flow.

Authors:  Tracy J Robinson; Jeffrey D Robinson; Daniel S Hippe; Lee M Mitsumori
Journal:  J Digit Imaging       Date:  2013-06       Impact factor: 4.056

Review 6.  Tailoring protocols for chest CT applications: when and how?

Authors:  Roberto Iezzi; Anna Rita Larici; Paola Franchi; Riccardo Marano; Nicola Magarelli; Alessandro Posa; Biagio Merlino; Riccardo Manfredi; Cesare Colosimo
Journal:  Diagn Interv Radiol       Date:  2017 Nov-Dec       Impact factor: 2.630

7.  Feasibility of contrast material volume reduction in coronary artery imaging using 320-slice volume CT.

Authors:  Patrick A Hein; Juliane May; Patrik Rogalla; Craig Butler; Bernd Hamm; Alexander Lembcke
Journal:  Eur Radiol       Date:  2009-12-17       Impact factor: 5.315

8.  Biphasic contrast medium injection in cardiac CT: moderate versus high concentration contrast material at identical iodine flux and iodine dose.

Authors:  Annemarieke Rutten; Matthijs F L Meijs; Alexander M de Vos; Peter R Seidensticker; Mathias Prokop
Journal:  Eur Radiol       Date:  2010-03-20       Impact factor: 5.315

9.  ASCI 2010 contrast media guideline for cardiac imaging: a report of the Asian Society of Cardiovascular Imaging cardiac computed tomography and cardiac magnetic resonance imaging guideline working group.

Authors:  Masahiro Jinzaki; Kakuya Kitagawa; I-Chen Tsai; Carmen Chan; Wei Yu; Hwan Seok Yong; Byoung Wook Choi
Journal:  Int J Cardiovasc Imaging       Date:  2010-10-08       Impact factor: 2.357

10.  Optimizing contrast medium injection protocol individually with body weight for high-pitch prospective ECG-triggering coronary CT angiography.

Authors:  Jie Liu; Jianbo Gao; Runze Wu; Yonggao Zhang; Lili Hu; Ping Hou
Journal:  Int J Cardiovasc Imaging       Date:  2013-01-04       Impact factor: 2.357

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.